"HMB-002 is the first fixed-dose subcutaneously administered antibody-based preventative therapy aiming to transform daily life for patients." HMB-002 is a monovalent antibody uniquely designed to ...

Local reactions, consisting mostly of mild or moderate pain, were least frequent with monovalent HA. Antibody concentrations to both antigens were similar in groups A and B, in which HA ...

A single dose of hepatitis A vaccine is sufficient to convey rapid immunity, with nearly all subjects developing hepatitis A antibodies ... vaccine with the monovalent hepatitis A and B vaccines.

At the same time, bispecific antibodies reduce the likelihood of unintended effects on healthy cells that express only one of the two targets, because the monovalent binding by one arm of the ...